India Pesticides Ltd
India Pesticides Limited is one of the globally operating agro-chemical manufactures in India, since 1984. The company is the sole Indian manufacturer and among the top five manufacturers globally for several Technicals, such as Folpet, Thiocarbamate Herbicide, and several other products [1]
- Market Cap ₹ 2,075 Cr.
- Current Price ₹ 180
- High / Low ₹ 246 / 120
- Stock P/E 19.4
- Book Value ₹ 83.6
- Dividend Yield 0.42 %
- ROCE 13.0 %
- ROE 9.73 %
- Face Value ₹ 1.00
Pros
- Company is almost debt free.
- Company is expected to give good quarter
Cons
- The company has delivered a poor sales growth of 11.6% over past five years.
- Company has a low return on equity of 12.2% over last 3 years.
- Dividend payout has been low at 10.1% of profits over last 3 years
- Company has high debtors of 152 days.
- Promoter holding has decreased over last 3 years: -3.55%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| 223 | 248 | 341 | 480 | 649 | 716 | 885 | 681 | 829 | 945 | |
| 163 | 193 | 275 | 386 | 466 | 502 | 687 | 594 | 708 | 791 | |
| Operating Profit | 60 | 55 | 65 | 94 | 183 | 214 | 198 | 87 | 121 | 154 |
| OPM % | 27% | 22% | 19% | 20% | 28% | 30% | 22% | 13% | 15% | 16% |
| 2 | 3 | 5 | 10 | 6 | 13 | 13 | 15 | 15 | 20 | |
| Interest | 6 | 4 | 6 | 5 | 3 | 7 | 6 | 4 | 4 | 5 |
| Depreciation | 3 | 4 | 4 | 5 | 6 | 8 | 11 | 15 | 18 | 20 |
| Profit before tax | 53 | 50 | 61 | 93 | 180 | 212 | 193 | 84 | 114 | 149 |
| Tax % | 33% | 35% | 28% | 24% | 25% | 25% | 25% | 27% | 26% | |
| 35 | 33 | 44 | 71 | 135 | 158 | 144 | 61 | 84 | 107 | |
| EPS in Rs | 1,113.42 | 1,030.79 | 1,379.83 | 2,224.32 | 12.04 | 13.75 | 12.54 | 5.31 | 7.33 | 9.30 |
| Dividend Payout % | 2% | 2% | 1% | 1% | 3% | 5% | 6% | 14% | 10% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 5% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 4% |
| 3 Years: | -19% |
| TTM: | 49% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -11% |
| 1 Year: | -2% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 18% |
| 3 Years: | 12% |
| Last Year: | 10% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 11 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 107 | 141 | 184 | 254 | 378 | 627 | 763 | 816 | 892 | 951 |
| 43 | 46 | 61 | 28 | 30 | 15 | 6 | 20 | 56 | 31 | |
| 42 | 51 | 69 | 81 | 97 | 131 | 135 | 148 | 183 | 273 | |
| Total Liabilities | 195 | 240 | 317 | 366 | 517 | 784 | 915 | 996 | 1,142 | 1,266 |
| 61 | 69 | 70 | 99 | 124 | 163 | 237 | 267 | 313 | 336 | |
| CWIP | 3 | 3 | 5 | 1 | 12 | 44 | 27 | 41 | 36 | 27 |
| Investments | 2 | 3 | 3 | 3 | 10 | 20 | 17 | 41 | 59 | 79 |
| 130 | 165 | 239 | 262 | 371 | 557 | 635 | 647 | 735 | 824 | |
| Total Assets | 195 | 240 | 317 | 366 | 517 | 784 | 915 | 996 | 1,142 | 1,266 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| 38 | 16 | -3 | 75 | 83 | 77 | 46 | 120 | 6 | |
| -6 | -13 | -7 | -31 | -84 | -133 | -23 | -125 | -5 | |
| -32 | -2 | 9 | -39 | -4 | 71 | -29 | 3 | 24 | |
| Net Cash Flow | 0 | 1 | -1 | 5 | -5 | 14 | -6 | -3 | 26 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 143 | 184 | 191 | 139 | 120 | 126 | 108 | 128 | 152 |
| Inventory Days | 56 | 75 | 60 | 88 | 163 | 175 | 201 | 204 | |
| Days Payable | 108 | 116 | 95 | 92 | 110 | 74 | 90 | 101 | |
| Cash Conversion Cycle | 143 | 132 | 150 | 104 | 116 | 179 | 209 | 240 | 255 |
| Working Capital Days | 102 | 110 | 128 | 119 | 120 | 159 | 164 | 184 | 179 |
| ROCE % | 32% | 30% | 37% | 52% | 41% | 28% | 11% | 13% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13 Nov - Audio recording of India Pesticides earnings call for Q2/H1 ended 30 Sep 2025 available; results approved 11 Nov 2025.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
12 Nov - Investor Presentation in connection with Unaudited Financial Results for the quarter & half year ended 30th September, 2025.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
12 Nov - Q2 revenue ₹295 Cr, PAT ₹32 Cr; Board approved ₹65 Cr backward-integration (26 DEA) project.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
12 Nov - Newspaper Publication in connection with Unaudited Financial Results for the quarter & half year ended 30th September, 2025.
- Financial Results For The Quarter And Half Year Ended 30Th September, 2025 11 Nov
Annual reports
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025Transcript PPT
-
Jun 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024TranscriptPPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
Jun 2023TranscriptPPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
Feb 2022Transcript PPT
-
Feb 2022TranscriptNotesPPT
-
Oct 2021TranscriptNotesPPT
-
Jul 2021Transcript PPT
Leading pesticides company [1]
An R&D-driven chemical manufacturer of agrochem technical, APIs, and formulation business.